Korean Circulation Journal

  • 제42권2호
  • /
  • Pages.118-121
  • /
  • 2012
  • /
  • 1738-5520(pISSN)
  • /
  • 1738-5555(eISSN)
대한심장학회 (The Korean Society of Cardiology)
권호 표지
DOI QR코드

DOI QR Code

Recurrent Very Late Stent Thrombosis in a Systemic Lupus Erythematous Patient

  • Lee, Dong-Yob (Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Park, Jong-Pil (Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Ko, Sung-Jun (Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Lee, Shin-Eun (Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Jhon, Sung-Hee (Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Lim, Ji-Hyun (Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center) ;
  • Rhew, Jay-Young (Division of Cardiology, Department of Internal Medicine, Presbyterian Medical Center)
  • 발행 : 2012.02.29
⟨ 이전 논문 다음 논문 ⟩

초록

Coronary artery disease is the most important cause of mortality in patients with systemic lupus erythematous (SLE). After stenting for coronary artery disease in SLE patients similar to non-SLE patients, the risk of stent thrombosis is always present. Although there are reports of stent thrombosis in SLE patients, very late recurrent stent thrombosis is rare. We experienced a case of very late recurrent stent thrombosis (4 times) in a patient with SLE.

키워드

참고문헌

  1. Haider YS, Roberts WC. Coronary arterial disease in systemic lupus erythematous: quantification of degree of narrowing in 22 necropsy patients (21 women) aged 16 to 37 years. Am J Med 1981;70:775-81. https://doi.org/10.1016/0002-9343(81)90532-5
  2. Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349:2399-406. https://doi.org/10.1056/NEJMoa035471
  3. Metha PK, Samday H, Vassiliades TA, Book WM. Acute coronary syndrome as a first presentation of systemic lupus erythematosus in a teenager: revascularization by hybrid coronary artery bypass graft surgery and percutaneous coronary intervention: case report. Pediatr Cardiol 2008;29:957-61. https://doi.org/10.1007/s00246-007-9157-0
  4. Kassaian S, Goodarzynejad H, Darabian S, Basiri Z. Myocardial infarction secondary to premature coronary artery disease as the initial major manifestation of systemic lupus erythematous. Cardiovas J Afr 2008; 19:152-4.
  5. Lee CH, Chong E, Low A, Lim J, Lme YT, Tan HC. Long-term follow-up after percutaneous coronary intervention in patients with systemic lupus erythematous. Int J Cardiol 2008;126:430-2. https://doi.org/10.1016/j.ijcard.2007.01.117
  6. Lee CH, Chan MY. Dilemma of drug-eluting stent implantation in a patient with systemic lupus erythematosus. Int J Cardiol 2007;114:e107-8. https://doi.org/10.1016/j.ijcard.2006.07.197
  7. Olivier AC, Hollman JL. Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin. J Invasive Cardiol 2006;18:E185-7.
  8. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308. https://doi.org/10.1097/01.md.0000091181.93122.55
  9. Moon YG, Kim YJ, Jeon DS, et al. A case of premature coronary atherosclerosis associated with systemic lupus erythematosus. Korean Circ J 1995;25:691-7. https://doi.org/10.4070/kcj.1995.25.3.691
  10. Muir DF, Stevens A, Napier-Hemy RO, Fath-Ordoubadi F, Curzen N. Recurrent stent thrombosis associated with lupus anticoagulant due to renal cell carcinoma. Int J Cardiovasc Intervent 2003;5:44-6. https://doi.org/10.1080/14628840304613
  11. Su HM, Lee KT, Chu CS, Sheu SH, Lai WT. Acute thrombosis after elective direct intracoronary stenting in primary antiphospholipid syndrome: a case report. Kaohsiung J Med Sci 2003;19:177-82. https://doi.org/10.1016/S1607-551X(09)70468-1
  12. Lee KH, Lee SW, Lee JW, et al. The significance of clopidogrel low-responsiveness on stent thrombosis and cardiac death assessed by the verifynow p(2)y(12) assay in patients with acute coronary syndrome within 6 months after drug-eluting stent implantation. Korean Circ J 2009;39:512-8. https://doi.org/10.4070/kcj.2009.39.12.512
  13. Lee CW, Kang SJ, Park DW, et al. Intravascular ultrasound findings in patients with very late stent thrombosis after either drug-eluting or bare-metal stent implantation. J Am Coll Cardiol 2010;55:1943-4. https://doi.org/10.1016/j.jacc.2009.11.088